Oncology

News

An AI could help to detect aggressive interval breast cancers that are diagnosed in between routine screening appointments, say US researchers.

News

GSK has become the latest drugmaker to run into difficulties in developing a drug targeting the immune checkpoint receptor TIM-3.

News

Celcuity shares rocket on a big win for its lead drug gedatolisib in advanced breast cancer, catapulting its value to almost $1.4 billion.

News

Bayer files its oral HER2+ lung cancer drug in China, as it extends a race to market with rival Boehringer Ingelheim.

R&D

The second quarter of 2025 has seen a surge of clinical trial activity across the pharmaceutical and biotech landscape.

News

Scancell has the results it was hoping for with its melanoma immunotherapy iSCIB1+ and is accelerating plans for a pivotal trial.